A mechanism for localized dynamics-driven activation in Bruton's tyrosine kinase

被引:2
|
作者
Qiu, Simei [1 ,2 ]
Liu, Yunfeng [1 ]
Li, Quhuan [1 ,2 ,3 ]
机构
[1] South China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Peoples R China
[2] South China Univ Technol, Guangdong Prov Engn & Technol Res Ctr Biopharmace, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China
来源
ROYAL SOCIETY OPEN SCIENCE | 2021年 / 8卷 / 08期
基金
中国国家自然科学基金;
关键词
activation mechanism; Bruton's tyrosine kinase; T474M mutation; X-LINKED AGAMMAGLOBULINEMIA; IRREVERSIBLE INHIBITORS; TARGETING BTK; IBRUTINIB; DISCOVERY; MUTATION; PATHWAY; BINDING; CANCER; CELLS;
D O I
10.1098/rsos.210066
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bruton's tyrosine kinase (BTK) plays a vital role in mature B-cell proliferation, development and function. Its inhibitors have gradually been applied for the treatment of many B-cell malignancies. However, because of treatment-associated drug resistance or low efficacy, it is urgent to develop new inhibitors and/or improve the efficacy of current inhibitors, where finding the intrinsic activation mechanism becomes the key to solve this problem. Here, we used BTK T474M mutation as a resistance model for inhibitors to study the mechanism of BTK activation and drug resistance by free molecular dynamics simulations. The results showed that the increase of kinase activity of T474M mutation is coming from the conformation change of the activation ring and ATP binding sites located in BTK N-terminus region. Specifically, the Thr(474) mutation changed the structure of A-loop and stabilized the binding site of ATP, thus promoting the catalytic ability in the kinase domain. This localized dynamics-driven activation mechanism and resistance mechanism of BTK may provide new ideas for drug development in B-cell malignancies.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Bruton's Tyrosine Kinase as a Drug Discovery Target
    Pan, Zhengying
    DRUG NEWS & PERSPECTIVES, 2008, 21 (07) : 357 - 362
  • [42] Cardiovascular Toxicities of Bruton’s Tyrosine Kinase Inhibitors
    Ricardo Pineda-Gayoso
    Mohammed Alomar
    Dae Hyun Lee
    Michael G. Fradley
    Current Treatment Options in Oncology, 2020, 21
  • [43] Bruton's Tyrosine Kinase Inhibitors: Recent Updates
    Fares, Amneh
    Uribe, Carlos Carracedo
    Martinez, Diana
    Rehman, Tauseef
    Rondon, Carlos Silva
    Sandoval-Sus, Jose
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [44] Cardiovascular Toxicities of Bruton's Tyrosine Kinase Inhibitors
    Pineda-Gayoso, Ricardo
    Alomar, Mohammed
    Lee, Dae Hyun
    Fradley, Michael G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (08)
  • [45] Pinning down Bruton's tyrosine kinase (Btk)
    Vargas, Leonardo
    Yu, Liang
    Mohamed, Abdalla J.
    Berglof, Anna
    Smith, C. I. Edvard
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [46] Bruton's Tyrosine Kinase Targeting in Multiple Myeloma
    Von Suskil, Max
    Sultana, Kazi Nasrin
    Elbezanti, Weam Othman
    Al-Odat, Omar S.
    Chitren, Robert
    Tiwari, Amit K.
    Challagundla, Kishore B.
    Srivastava, Sandeep Kumar
    Jonnalagadda, Subash C.
    Budak-Alpdogan, Tulin
    Pandey, Manoj K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [47] Role of Bruton’s tyrosine kinase in macrophage apoptosis
    Anupriya Khare
    Bharathi Viswanathan
    Rupali Gund
    Nidhi Jain
    Balachandran Ravindran
    Anna George
    Satyajit Rath
    Vineeta Bal
    Apoptosis, 2011, 16 : 334 - 346
  • [48] Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis
    Schneider, Raphael
    Oh, Jiwon
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2022, 22 (11) : 721 - 734
  • [49] Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
    Raphael Schneider
    Jiwon Oh
    Current Neurology and Neuroscience Reports, 2022, 22 : 721 - 734
  • [50] Regulation of Bruton's tyrosine kinase by phosphorylation.
    Wahl, MI
    Park, H
    Rawlings, DJ
    Witte, ON
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A124 - A124